Drug Type Small molecule drug |
Synonyms AR 08, PGE-6134091 |
Target |
Mechanism ADRA2 agonists(Adrenergic receptors alpha-2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H16N6O2 |
InChIKeyPHBLJFKGZMOGFS-UHFFFAOYSA-N |
CAS Registry745048-53-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vasomotor symptom | Phase 2 | US | 01 Jan 2014 | |
Attention Deficit Disorder With Hyperactivity | Phase 2 | US | 01 Jun 2013 |